bwge2018 has ended

Create Your Own Event

bwge2018

Belgian Week of Gastroenterology 2018

13:15 CET

Satellite symposium: Janssen-Cilag : Targeting IL-23/-12 in Crohn’s disease : experience from across the border Room LIJN (3th floor)Tanja Kühbacher Satellite symposium: Janssen-Cilag : Targeting IL-23/-12 in Crohn’s disease : experience from across the border Room LIJN (3th floor)Tanja Kühbacher

14:00 CET

INVITED LECTURE: Why animal models of IBD are still relevant Room LIJN (3th floor)Massimo Fantini

14:25 CET

Aberrant Muc1 and Muc13 expression in association with Par polarity complex and Vip dysfunction in a colitis T cell transfer model Room LIJN (3th floor)Tom Breugelmans

14:35 CET

Transcriptomic profile of inflamed colonic biopsies from newly diagnosed Crohn’s disease and ulcerative colitis patients depend on the age at diagnosis Room LIJN (3th floor)Sare Verstockt

14:45 CET

Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn’s disease Room LIJN (3th floor)Brecht Creyns

14:55 CET

Endoplasmic Reticulum stress in bordering epithelium of Crohn’s disease patients with intestinal fibrosis Room LIJN (3th floor)Shurong Hu

15:05 CET

INVITED LECTURE: Benefits and limitations of pre-clinical in vitro and ex vivo work Room LIJN (3th floor)Wiebe Vanhove

16:00 CET

Serum proteomic analysis characterizes newly diagnosed Crohn’s disease and ulcerative colitis depending on the age at diagnosis Room LIJN (3th floor)Sare Verstockt

16:10 CET

Serum proteomic profiling reveals changes in inflammatory profiles with consecutive biological therapies in patients with inflammatory bowel disease Room LIJN (3th floor)Magali de Bruyn

16:20 CET

Protein biomarkers identify subclinical inflammation patterns in first-degree relatives of patients with inflammatory bowel disease Room LIJN (3th floor)Maaike Vancamelbeke

16:30 CET

Decreased leukocyte trafficking may contribute to vedolizumab refractory disease after anti-TNF exposure in patients with ulcerative colitis Room LIJN (3th floor)Bram Verstockt

16:40 CET

INVITED LECTURE: The exposome in IBD: what needs to be done? Room LIJN (3th floor)Gerhard Rogler

17:00 CET

Satelite symposium Pfizer: New MOAs/pathways in the IBD world Room LIJN (3th floor)Charlie Lees Satelite symposium Pfizer: New MOAs/pathways in the IBD world Room LIJN (3th floor)Charlie Lees

17:45 CET

BIRD General Assembly Room LIJN (3th floor)

13:15 CET

Satellite symposium Takeda: PK/PD for guiding therapy with vedolizumab: lessons from clinical experience Room LIJN (3th floor)Shomron Ben-Horin Satellite symposium Takeda: PK/PD for guiding therapy with vedolizumab: lessons from clinical experience Room LIJN (3th floor)Shomron Ben-Horin

14:00 CET

INVITED LECTURE: JAK inhibitors: can they replace biologicals? Room LIJN (3th floor)Charlie Lees

14:25 CET

Thiopurine monotherapy still has a place in the treatment of patients with mild-to-moderate Crohn’s disease in the biological era Room LIJN (3th floor)Liesbeth Boets

14:35 CET

Ustekinumab induces clinical and biological remission in biologic refractory crohn's disease patients Room LIJN (3th floor)Claire Liefferinckx

14:45 CET

Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments Room LIJN (3th floor)Hommel Christophe

14:55 CET

Ustekinumab induces limited mucosal healing after 6 months in a real-life, prospective cohort of patients with refractory Crohn’s disease Room LIJN (3th floor)Bram Verstockt

15:05 CET

INVITED LECTURE: JAK inhibitors: is the increased risk of viral infections a real threat? Room LIJN (3th floor)Marc Van Ranst

16:00 CET

Effectiveness and persistence of vedolizumab in patients with inflammatory bowel disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE) Room LIJN (3th floor)Catherine Reenaers

16:10 CET

Vedolizumab trough levels during induction in IBD patients: a longitudinal observational retrospective study Room LIJN (3th floor)Claire Liefferinckx

16:20 CET

Vedolizumab can induce clinical remission in patients with chronic antibiotic-refractory pouchitis: a retrospective single centre experience Room LIJN (3th floor)Charlotte Claeys

16:30 CET

Outcome of pregnancies in vedolizumab treated female IBD patients Room LIJN (3th floor)Annick Moens

16:40 CET

INVITED LECTURE: Initiating biological therapies in IBD: do I have to use other drugs for CD than for UC? Room LIJN (3th floor)Shomron Ben-Horin

09:00 CET

Introduction Room LIJN (3th floor)A. Hoorens

09:05 CET

INVITED LECTURE : Non-HP gastritis Room LIJN (3th floor)M. Rugge

09:40 CET

An unusual gastric polyp Room LIJN (3th floor)C. Van Paesschen

09:50 CET

Granular cytoplasmic expression of calretinin in Schwann cell hamartomas Room LIJN (3th floor)Louis Libbrecht

10:45 CET

INVITED LECTURE: Non-IBD colitis Room LIJN (3th floor)G. Cathomas

11:20 CET

Myxoid hepatocellular adenoma, a rare variant of liver cell adenoma, often clinically misdiagnosed as cavernous haemangioma Room LIJN (3th floor)Anne Hoorens

11:30 CET

INVITED LECTURE: Auto-immune enteropathy Room LIJN (3th floor)Ann DRIESSEN

14:00 CET

Introduction to the Brohée Prize Room LIJN (3th floor)Ivan Borbath

14:05 CET

Brohée Prize Lecture: Personalized medicine in GI oncology: myth or reality Room LIJN (3th floor)S. Tejpar

14:30 CET

INVITED LECTURE: Neuroendocrine neoplasms of the GI tract: NET, NEC and MiNEN in the WHO 2017 classification Room LIJN (3th floor)Anne Hoorens

15:00 CET

Frequency of epidermal metaplasia in a retrospective monocentric series of mucosectomy for esophageal intraepithelial neoplasia and/or superficial squamous cell carcinoma Room LIJN (3th floor)Fouad AL ZUBI

15:10 CET

Endothelial indoleamine 2,3-dioxygenase expression in colorectal cancer: an early marker of disease relapse Room LIJN (3th floor)ANNABEL MEIRESON

15:45 CET

Case presentations of “Non-HP-gastritis” and “Non-IBD colitis”. Room LIJN (3th floor)H. Van Beveren • S. Bigoundou-Nzamba • G. Broeckx • A. Candaele • P. Henry • A. De Roo

16:45 CET

INVITED LECTURE: Disorders of the colon secondary to diagnostic procedures and treatments unrelated to drugs Room LIJN (3th floor)L. Libbrecht